Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Covista Inc.ATGE · Entity 3964 | Pres. - Adtalem Med & Vet | August 25, 2023 | August 29, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Covista Inc.
Report date August 25, 2023 · Filed August 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,718 |
Reported balance
After 2023-08-25 transaction · row 1
1 source rowRow 1 · 2023-08-25 · Tax withholding · Disposed 2,949 · Balance 38,718 F1: Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2023 Filed Aug 29, 2023 20:12 UTC | Covista Inc. ATGE · Entity 3964 | Tax withholdingCommon Stock | 2,949 | $43.20 | $127,396.80 |
DisclosureSEC source: 0001127602-23-023347 · form4.xml · nonDerivative · entry 1 DANAHER JOHN W MD · CIK 0001309445 · Pres. - Adtalem Med & Vet 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,718 F1 · shares: Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. Read SEC document |
| August 24, 2023 Filed Aug 25, 2023 22:47 UTC | Covista Inc. ATGE · Entity 3964 | Tax withholdingCommon Stock | 419 | $43.47 | $18,213.93 |
DisclosureSEC source: 0001127602-23-023264 · form4.xml · nonDerivative · entry 1 DANAHER JOHN W MD · CIK 0001309445 · Pres. - Adtalem Med & Vet 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,667 F1 · shares: Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. Read SEC document |
| August 25, 2022 Filed Aug 26, 2022 20:24 UTC | Covista Inc. ATGE · Entity 3964 | Tax withholdingCommon Stock | 2,934 | $41.12 | $120,646.08 |
DisclosureSEC source: 0001127602-22-021625 · form4.xml · nonDerivative · entry 2 DANAHER JOHN W MD · CIK 0001309445 · Pres. - Adtalem Med & Vet 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,086 F2 · shares: Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:24 UTC | Covista Inc. ATGE · Entity 3964 | GrantCommon Stock | 4,420 | $39.74 | $175,650.80 |
DisclosureSEC source: 0001127602-22-021625 · form4.xml · nonDerivative · entry 1 DANAHER JOHN W MD · CIK 0001309445 · Pres. - Adtalem Med & Vet 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,020 F1 · shares: Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on August 24, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.